Endeavor's ENV-101 improves lung function in Phase IIa IPF trial
ENV-101 was found to be well-tolerated in the trial without any serious adverse events reported.
Stay updated with breaking news from Trials Arena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ENV-101 was found to be well-tolerated in the trial without any serious adverse events reported.
While the export of life-saving pharmaceuticals does not fall under sanctions for ethical reasons, all major pharma companies have vowed to stop new...
While the export of life-saving pharmaceuticals does not fall under sanctions for ethical reasons, all major pharma companies have vowed to stop new...
Apart from pancreatic ductal adenocarcinoma, studies in liver disease, venous leg ulcer, sleep apnoea, and ocular issues are also reviewed.
Can AI potentially help participants stick to the study all the way to the end, while also pointing to clinical trial sponsor blind spots?